152 related articles for article (PubMed ID: 23283868)
1. Hepatic dysfunction after radiotherapy for primary gastric lymphoma.
Tanaka H; Hayashi S; Ohtakara K; Hoshi H
J Radiat Res; 2013 Jan; 54(1):92-7. PubMed ID: 23283868
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
[TBL] [Abstract][Full Text] [Related]
3. Radiation-Induced Liver Injury in Three-Dimensional Conformal Radiation Therapy (3D-CRT) for Postoperative or Locoregional Recurrent Gastric Cancer: Risk Factors and Dose Limitations.
Li G; Wang J; Hu W; Zhang Z
PLoS One; 2015; 10(8):e0136288. PubMed ID: 26291715
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
Minn AY; Hsu A; La T; Kunz P; Fisher GA; Ford JM; Norton JA; Visser B; Goodman KA; Koong AC; Chang DT
Cancer; 2010 Aug; 116(16):3943-52. PubMed ID: 20564136
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
[TBL] [Abstract][Full Text] [Related]
6. Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy.
White EC; Murphy JD; Chang DT; Koong AC
Am J Clin Oncol; 2015 Dec; 38(6):564-9. PubMed ID: 24401668
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
[TBL] [Abstract][Full Text] [Related]
10. Assessment of renal function after conformal radiotherapy and intensity-modulated radiotherapy by functional 1H-MRI and 23Na-MRI.
Haneder S; Michaely HJ; Schoenberg SO; Konstandin S; Schad LR; Siebenlist K; Wertz H; Wenz F; Lohr F; Boda-Heggemann J
Strahlenther Onkol; 2012 Dec; 188(12):1146-54. PubMed ID: 23111472
[TBL] [Abstract][Full Text] [Related]
11. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
[TBL] [Abstract][Full Text] [Related]
12. Reduced dose to small bowel with the prone position and a belly board versus the supine position in neoadjuvant 3D conformal radiotherapy for rectal adenocarcinoma.
White R; Foroudi F; Sia J; Marr MA; Lim Joon D
J Med Radiat Sci; 2017 Jun; 64(2):120-124. PubMed ID: 27741381
[TBL] [Abstract][Full Text] [Related]
13. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
[TBL] [Abstract][Full Text] [Related]
14. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
[TBL] [Abstract][Full Text] [Related]
15. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
Pinnix CC; Gunther JR; Milgrom SA; Cruz Chamorro RJ; Medeiros LJ; Khoury JD; Amini B; Neelapu S; Lee HJ; Westin J; Fowler N; Nastoupil L; Dabaja B
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):447-455. PubMed ID: 30769175
[TBL] [Abstract][Full Text] [Related]
16. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
[TBL] [Abstract][Full Text] [Related]
17. Plan Quality Comparisons Between 3D-CRT, IMRT, and VMAT Based on 4D-CT for Gastric MALT Lymphoma.
Matsumoto T; Toya R; Shimohigashi Y; Watakabe T; Matsuyama T; Saito T; Fukugawa Y; Kai Y; Oya N
Anticancer Res; 2021 Aug; 41(8):3941-3947. PubMed ID: 34281857
[TBL] [Abstract][Full Text] [Related]
18. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?
De Sanctis V; Bolzan C; D'Arienzo M; Bracci S; Fanelli A; Cox MC; Valeriani M; Osti MF; Minniti G; Chiacchiararelli L; Enrici RM
Radiat Oncol; 2012 Aug; 7():129. PubMed ID: 22857015
[TBL] [Abstract][Full Text] [Related]
19. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).
Wang X; Li G; Zhang Y; Bai S; Xu F; Wei Y; Gong Y
Med Dosim; 2013; 38(4):395-400. PubMed ID: 23791504
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
